Showing results (21-30 of 571) with videos related to
Sort By:
Pageof 58
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|August 14, 2001
Red blood cell transfusion strategiesM A Blajchman, P C HébertImmunological Investigations|January 1, 1995
The tumor growth-promoting effect of allogeneic blood transfusionsM A Blajchman, J O BordinThrombosis Research|August 1, 1994
Amino acid substitutions of the P2 residue of human antithrombin that either enhance or impair functionW P Sheffield, M A BlajchmanFEBS Letters|February 14, 1994
Site-directed mutagenesis of the P2 residue of human antithrombinW P Sheffield, M A BlajchmanFEBS Letters|May 29, 1995
Deletion mutagenesis of heparin cofactor II: defining the minimum size of a thrombin inhibiting serpinW P Sheffield, M A BlajchmanHematology/Oncology Clinics of North America|February 1, 1995
Immunosuppressive effects of allogeneic blood transfusions: implications for the patient with a malignancyJ O Bordin, M A BlajchmanTransfusion Medicine Reviews|July 1, 1995
Noninfectious adverse effects of blood transfusion in the neonateP Holman, M A Blajchman, N HeddleArchives of Pathology & Laboratory Medicine|January 1, 1992
Pseudopolycythemia, pseudothrombocytopenia, and pseudoleukopenia due to overfilling of blood collection vacuum tubesW Pewarchuk, J VanderBoom, M A BlajchmanTransfusion|January 1, 1981
Studies on the blood of an MiV homozygoteV Vengelen-Tyler, D J Anstee, P D Issitt, et al.Blood|July 1, 1994
Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion: the importance of the timing of the leukodepletionJ O Bordin, L Bardossy, M A BlajchmanPageof 58